THC Therapeutics, Inc. (THCT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -85.43 Thousand | -418.91 Thousand | -388.47 Thousand | -587.93 Thousand | -329.8 Thousand | -190.16 Thousand |
| Net Income | -387.03 Thousand | -1.51 Million | -1.88 Million | -1.92 Million | -23.3 Million | -6.13 Million |
| Depreciation & Amortization | 1393.00 | 12.33 Thousand | 16.37 Thousand | 20.11 Thousand | 25.55 Thousand | 25.43 Thousand |
| Deferred income taxes | -355.97 Thousand | - | 393.71 Thousand | 94.74 Thousand | 6.51 Million | 5.26 Million |
| Stock-based compensation | 87.17 Thousand | 836.78 Thousand | 115.69 Thousand | 438.43 Thousand | 23.82 Million | 466.64 Thousand |
| Change in working capital | 398.64 Thousand | 563.7 Thousand | 513.38 Thousand | 357.58 Thousand | 226.85 Thousand | 109.31 Thousand |
| Other non-cash items | 170.37 Thousand | -312.81 Thousand | 457.8 Thousand | 426.37 Thousand | -7.61 Million | 80.05 Thousand |
| Investing Cash Flow | - | - | -152.78 Thousand | - | -1195.00 | -532.00 |
| Investments in PPE | 2.00 | - | - | - | -1195.00 | -532.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -152.78 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -152.79 | - | -1195.00 | - |
| Financing Cash Flow | 85.41 Thousand | 122.81 Thousand | 794.15 Thousand | 313.62 Thousand | 645.58 Thousand | 193.47 Thousand |
| Debt repayment | -14.59 Thousand | -54.56 Thousand | -103.42 Thousand | -266.41 Thousand | -240.95 Thousand | -116.18 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -97.5 Thousand | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 147 Thousand | 506.5 Thousand | - | - | 65 Thousand |
| Other Financing Activities | -14.59 Thousand | 127.88 Thousand | 391.08 Thousand | 580.03 Thousand | 886.53 Thousand | 244.66 Thousand |
| Accounts receivables | -355.94 Thousand | - | - | - | - | - |
| Accounts payables | 358.93 Thousand | 598.97 Thousand | 418.79 Thousand | 217.33 Thousand | 226.85 Thousand | 106.1 Thousand |
| Inventory | 25.00 | 805.00 | -830.00 | - | - | - |
| Other working capital | 395.63 Thousand | -36.07 Thousand | 95.41 Thousand | 140.25 Thousand | 226.85 Thousand | 3208.00 |
| Cash at beginning of period | 32.00 | 296.13 Thousand | 43.23 Thousand | 317.55 Thousand | 2969.00 | 187.00 |
| Cash at end of period | 10.00 | 32.00 | 296.13 Thousand | 43.23 Thousand | 317.55 Thousand | 2969.00 |
| Capital Expenditure | 2.00 | - | - | - | -1195.00 | -532.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -22.00 | -296.09 Thousand | 252.89 Thousand | -274.31 Thousand | 314.58 Thousand | 2782.00 |
| Free Cash Flow | -85.43 Thousand | -418.91 Thousand | -388.47 Thousand | -587.93 Thousand | -330.99 Thousand | -190.69 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -571.97 Thousand | -62.48 Thousand | -32.94 Thousand | -387.03 Thousand | 94.35 Thousand | 1.68 Million |
| Depreciation & Amortization | 351.00 | 351.00 | 351.00 | 1393.00 | 340.00 | 351.00 |
| Deferred income taxes | - | - | - | -355.97 Thousand | - | - |
| Stock-based compensation | - | - | - | 87.17 Thousand | - | 65.89 Thousand |
| Change in working capital | 59.34 Thousand | 73.97 Thousand | 73.56 Thousand | 398.64 Thousand | 74.73 Thousand | 165.78 Thousand |
| Other non-cash items | 467.85 Thousand | -11.41 Thousand | -41.02 Thousand | 170.37 Thousand | -171.6 Thousand | -1.97 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 48.62 Thousand | 269.00 | 42.00 | 85.41 Thousand | -6642.00 | 66.99 Thousand |
| Debt repayment | -291.00 | -269.00 | -42.00 | -14.59 Thousand | -6642.00 | -33 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 48.92 Thousand | - | - | 100 Thousand | - | 100 Thousand |
| Other Financing Activities | -291.00 | 269.00 | 42.00 | -14.59 Thousand | -6642.00 | -33 Thousand |
| Accounts receivables | - | - | - | -355.94 Thousand | - | -0.02 |
| Accounts payables | 59.34 Thousand | 73 Thousand | 73.56 Thousand | 358.93 Thousand | 74.2 Thousand | 127.27 Thousand |
| Inventory | - | - | - | 25.00 | - | 0.03 |
| Other working capital | 59.34 Thousand | 73.97 Thousand | 73.56 Thousand | 395.63 Thousand | 524.00 | 38.5 Thousand |
| Cash at beginning of period | 10.00 | 10.00 | 15.00 | 32.00 | 8835.00 | 3561.00 |
| Cash at end of period | 3511.00 | 10.00 | 10.00 | 10.00 | 15.00 | 8835.00 |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3501.00 | - | -5.00 | -22.00 | -8820.00 | 5274.00 |
| Free Cash Flow | -45.13 Thousand | -269.00 | -47.00 | -85.43 Thousand | -2178.00 | -61.72 Thousand |
CRVC
SANO1
RSMX
1522
603633
SOCGP